Literature DB >> 24096845

Influenza vaccination in India: position paper of Indian Academy of Pediatrics, 2013.

V M Vashishtha1, A Kalra, P Choudhury.   

Abstract

Burden of Influenza is significantly higher in developing countries as compared to developed countries, but the data on the disease burden is less well defined in most of the developing countries including India, and consequently, constraints evolving strategies for prioritization of measures to prevent and control it. The swine flu or A(H1N1) pandemic is on the wane but the virus continues to circulate causing sporadic outbreaks even in 2013. The A(H1N1)pdm09 has replaced the previous circulating seasonal A (H1N1) virus and acquired the status of a seasonal virus. Limited influenza activity is usually seen throughout the year in India with a clear peaking during the rainy season. The rainy season in the country lasts from June to August in all the regions except Tamil Nadu where it occurs from October to December. IAP recommends the ideal time for offering influenza vaccines is just before the onset of rainy season. The efficacy/effectiveness data of trivalent inactivated influenza vaccines are also presented in different age groups and different categories of individuals. The IAP maintains its earlier recommendations of using the current trivalent inactivated influenza vaccine in all children with risk factors but not as a universal measure. IAP has now prioritized different target groups for influenza vaccination based on contribution of the group to the overall influenza burden, disease severity, and vaccine effectiveness in different age groups and categories. The current trivalent inactivated influenza vaccines incorporate the 2009 pandemic strain also, hence avert the need of a separate A (H1N1) vaccine. IAP stresses the need of more refined surveillance; large scale studies on effectiveness of seasonal influenza vaccines in Indian children, and more effective, properly matched, higher-valent influenza vaccines.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24096845     DOI: 10.1007/s13312-013-0230-x

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN: 0019-6061            Impact factor:   1.411


  6 in total

1.  Seroconversion and immunogenicity evaluation of seasonal influenza vaccine in mice model.

Authors:  Arti Bharmoria; Vipin Behari Vaish; K R Mani
Journal:  Virusdisease       Date:  2016-08-17

2.  Community awareness, use and preference for pandemic influenza vaccines in Pune, India.

Authors:  Neisha Sundaram; Vidula Purohit; Christian Schaetti; Abhay Kudale; Saju Joseph; Mitchell G Weiss
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Sterilizing immunity to influenza virus infection requires local antigen-specific T cell response in the lungs.

Authors:  Avijit Dutta; Ching-Tai Huang; Chun-Yen Lin; Tse-Ching Chen; Yung-Chang Lin; Chia-Shiang Chang; Yueh-Chia He
Journal:  Sci Rep       Date:  2016-09-06       Impact factor: 4.379

4.  Disparities in spread and control of influenza in slums of Delhi: findings from an agent-based modelling study.

Authors:  Abhijin Adiga; Shuyu Chu; Stephen Eubank; Christopher J Kuhlman; Bryan Lewis; Achla Marathe; Madhav Marathe; Eric K Nordberg; Samarth Swarup; Anil Vullikanti; Mandy L Wilson
Journal:  BMJ Open       Date:  2018-01-21       Impact factor: 2.692

5.  Influenza vaccination: Some clinical concerns for South Asian practitioner.

Authors:  Viroj Wiwanitkit
Journal:  Indian J Med Res       Date:  2019-08       Impact factor: 2.375

6.  Modelling monthly influenza cases in Malaysia.

Authors:  Muhammad Adam Norrulashikin; Fadhilah Yusof; Nur Hanani Mohd Hanafiah; Siti Mariam Norrulashikin
Journal:  PLoS One       Date:  2021-07-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.